Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint

by NASDAQ Market News December 23, 2019

NASDAQ Market News
Click here to email author

OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Clearance of its Unyvero LRT for BAL Specimens

Poultry Vaccines Market – Global Forecast to 2024: Avian Influenza is Expected to Lead the Market

Ads